Dr. Smith's ECG Blog
JUNE 5, 2024
Written by Magnus Nossen The patient in todays case is a 50 year old male. He has a medical hx notable for hypertension, hyperlipidemia and previous tobacco use disorder. The patient presented due to chest pain that was typical in nature, retrosternal and radiating to the left arm and neck. He denied any exertional chest pain. The below ECG was recorded.
Science Daily - Heart Disease
JUNE 5, 2024
Adolescents with elevated blood pressure and arterial stiffness may experience poorer cognitive functions, according to a recent study. Young people with higher blood pressure performed worse, especially in tasks that measured attention and learning. In addition, arterial stiffness was reflected in weaker working memory. In view of the findings, the importance of preventing high blood pressure and arterial stiffness in childhood and adolescence is emphasized.
DAIC
JUNE 5, 2024
Getty Images milla1cf Wed, 06/05/2024 - 20:33 June 5, 2024 — Edwards Lifesciences announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care.
Science Daily - Heart Disease
JUNE 5, 2024
New research has linked multiple types of per- and polyfluoroalkyl substances (PFAS, also known as 'forever chemicals') with increased risk of cardiovascular diseases in postmenopausal women. Specifically, the study reveals how PFAS chemicals interact with pro-inflammatory pathways in older women, providing potential explanations for the increased risk.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Med Page Today
JUNE 5, 2024
(MedPage Today) -- NEW YORK CITY -- Researchers eked out evidence of a small clinical benefit with the Sentinel cerebral embolic protection (CEP) device in transcatheter aortic valve replacement (TAVR) -- and pointed to the patients more likely.
HCPLive
JUNE 5, 2024
In an interview at SLEEP 2024, Brager talked about the benefits of exercise on cardiovascular health and sleep.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
CardiacWire
JUNE 5, 2024
Philips’ ultrasound AI strategy took another big step this week, with the launch of its next-generation echo AI platform, which will come integrated with the company’s cardiovascular ultrasound systems and bring a range of new echo-automating capabilities. Philips’ new AI-enabled cardiovascular ultrasound platform includes a combination of established and first-to-market AI applications that come fully integrated with its EPIQ CVx and Affiniti CVx echo scanners, with a focus on speeding up echo
Science Daily - Heart Disease
JUNE 5, 2024
Researchers have now proposed a molecular mechanism that links amyloid deposition in the aortic valve with degenerative calcification. They also theorize that other risk factors for CAVD, such as high blood levels of lipoprotein, can contribute to calcification both directly and indirectly through the mechanisms that involve amyloid accumulation.
HCPLive
JUNE 5, 2024
The VIO Skin Platform by Enspectra Health was designed to assess lesions indicating either basal cell carcinoma or squamous cell carcinoma.
Cardiovascular Diabetology
JUNE 5, 2024
Micro- and macrovascular diseases are common in patients with type 2 diabetes mellitus (T2D) and may be partly caused by nocturnal hypoxemia. The study aimed to characterize the composition of nocturnal hypoxe.
HCPLive
JUNE 5, 2024
In this episode, hosts provide their audience with an overview of a pair of new studies on the topic of diabetes in pregnancy: the GLAM and CRISTAL studies.
Cardiovascular Diabetology
JUNE 5, 2024
Cardiovascular disease (CVD) is closely associated with the triglyceride glucose (TyG) index and its related indicators, particularly its combination with obesity indices. However, there is limited research on.
HCPLive
JUNE 5, 2024
The biosimilars month in review highlights recent FDA approvals and successful comparison trials.
Cardiovascular Diabetology
JUNE 5, 2024
Recent studies have suggested that insulin resistance (IR) contributes to the development of cardiovascular diseases (CVD), and the estimated glucose disposal rate (eGDR) is considered to be a reliable surroga.
HCPLive
JUNE 5, 2024
Mona Shahriari, MD, discusses the evolving role of nonsteroidal topical options the management of plaque psoriasis.
Med Page Today
JUNE 5, 2024
(MedPage Today) -- BOSTON -- Some of the latest research advancements in hormonal health presented at the Endocrine Society's ENDO 2024 included a daily male birth control gel, semaglutide's taste sensitivity-boosting properties, and a novel.
HCPLive
JUNE 5, 2024
This month-in-review features an exclusive interview with Srinivas R. Sadda, MD, and promising data from studies on geographic atrophy, diabetic macular ischemia, diabetic retinopathy, and AMD.
Journal of Cardiothoracic Surgery
JUNE 5, 2024
Long QT Syndrome (LQTS) and Beckwith-Wiedemann Syndrome (BWS) are complex disorders with unclear origins, underscoring the need for in-depth molecular investigations into their mechanisms. The main aim of this.
HCPLive
JUNE 5, 2024
These data suggest an association between dietary sodium intake and severity of eczema among patients.
Journal of Cardiothoracic Surgery
JUNE 5, 2024
The most common type of cancer that leads to death worldwide is lung cancer. Despite significant surgery and chemotherapy improvements, lung cancer patient’s survival rate is still poor. The RNA polymerase I s.
HCPLive
JUNE 5, 2024
In our nephrology month in review for May 2024, we spotlight the biggest news from the NKF and ERA meetings, including the latest updates in IgA nephropathy, C3 glomerulopathy, chronic kidney disease, and more!
Cardiovascular Diabetology
JUNE 5, 2024
The triglyceride–glucose (TyG) index, a tool for assessing insulin resistance, is increasingly recognized for its ability to predict cardiovascular and metabolic risks.
HCPLive
JUNE 5, 2024
Parthasarathy discussed next steps for research on the relationship between sleep disturbances and immunity in an interview with HCPLive at SLEEP 2024.
Open Heart
JUNE 5, 2024
Background There is increasing awareness that patients without standard modifiable risk factors (SMuRFs; diabetes, hypercholesterolaemia, hypertension and smoking) may represent a unique subset of patients with acute coronary syndrome (ACS). We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRFs.
HCPLive
JUNE 5, 2024
Late-breaking phase 3 data presented at EASL show elafibranor’s impact on managing PBC progression and improving itch-related quality of life in patients with pruritus.
Frontiers in Cardiovascular Medicine
JUNE 5, 2024
BackgroundBehcet's disease (BD) is a systematic vasculitis that affects vessels with various sizes, presenting as venous thrombosis and arterial pseudoaneurysms. The most severe manifestation in BD is ascending aortic pseudoaneurysm, which is associated with high risks of rupture and mortality.Case presentationWe present a case of ascending aortic pseudoaneurysm in a 50-year-old patient with BD.
HCPLive
JUNE 5, 2024
The rheumatology month in review addresses opioid concerns and promotes holistic care in managing chronic conditions.
BoardVitals - Cardiovascular
JUNE 5, 2024
The journey to becoming a board-certified cardiologist includes the American Board of Internal Medicine (ABIM) subspecialty examination in cardiovascular disease. While this exam was always known for being challenging, a recent trend of declining pass rates has made preparing for the test more important than ever. What is driving the drop in pass rates, and how can you ensure you are ready for exam day?
HCPLive
JUNE 5, 2024
The panel explores issues surrounding medication adherence and the potential for improved patient engagement. They emphasize that poor medication adherence increases the risk of cardiovascular events and discuss factors such as drug cost, timing of administration, and the importance of adopting a patient-centric approach to optimize treatment success.
The American Journal of Cardiology
JUNE 5, 2024
Publication date: Available online 4 June 2024 Source: The American Journal of Cardiology Author(s): Ilan Merdler, Andrew P. Hill, Sevket Tolga Ozturk, Matteo Cellamare, Cheng Zhang, Kalyan R. Chitturi, Avantika Banerjee, Lior Lupu, Vaishnavi Sawant, Itsik Ben-Dor, Ron Waksman, Hayder D. Hashim, Brian C.
HCPLive
JUNE 5, 2024
Michael Koren, MD addresses the challenges posed by prior authorization and the diminished role of pharmaceutical sales representatives in informing providers about medication advancements, leading to a disconnect in the provider's treatment arsenal.
American College of Cardiology
JUNE 5, 2024
By advocating for evidence-based policies like CPR education, AED access and emergency action plan (EAP) implementation, cardiovascular societies like the ACC and American Heart Association are working in tandem with initiatives like the National Football League (NFL)-led Smart Heart Sports Coalition to improve outcomes in young athletes experiencing sudden cardiac arrest (SCA), according to a recent Viewpoint published in JACC: Advances.
HCPLive
JUNE 5, 2024
The key opinion leaders explore the utilization of biomarkers in guiding the treatment of severe or uncontrolled asthma, discussing the specific role of eosinophils in informing therapeutic decision-making for patients with challenging asthma cases.
American College of Cardiology
JUNE 5, 2024
In this week’s View, Dr. Eagle looks at anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting. He then examines a meta-analysis of invasive vs. conservative management of non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting.
HCPLive
JUNE 5, 2024
The expert panel discusses the use of biologics in treating asthma, explaining their mechanisms of action, differences, and target populations, while also examining trends in long-term efficacy and safety for patients with severe or uncontrolled asthma.
HeartRhythm
JUNE 5, 2024
Areas of abnormal and/or heterogenous conduction velocity (CV) are important ablation targets for ventricular tachycardias. Yet, precise assessment of CV in clinical contact mapping remains challenging. Numerous different CV estimation methods have been proposed.
Expert insights. Personalized for you.
123 
Let's personalize your content